3.425
price down icon0.58%   -0.015
 
loading
Precedente Chiudi:
$3.44
Aprire:
$3.46
Volume 24 ore:
123.94K
Relative Volume:
0.08
Capitalizzazione di mercato:
$194.23M
Reddito:
$195.82M
Utile/perdita netta:
$-88.78M
Rapporto P/E:
-1.3651
EPS:
-2.5089
Flusso di cassa netto:
$-88.86M
1 W Prestazione:
+3.32%
1M Prestazione:
-19.72%
6M Prestazione:
-35.10%
1 anno Prestazione:
-45.97%
Intervallo 1D:
Value
$3.39
$3.48
Intervallo di 1 settimana:
Value
$3.38
$3.67
Portata 52W:
Value
$3.28
$6.83

Aurora Cannabis Inc. Stock (ACB) Company Profile

Name
Nome
Aurora Cannabis Inc.
Name
Telefono
-
Name
Indirizzo
10355 Jasper Avenue, Suite 500, Edmonton, AB
Name
Dipendente
0
Name
Cinguettio
@Aurora_MMJ
Name
Prossima data di guadagno
2025-06-18
Name
Ultimi documenti SEC
Name
ACB's Discussions on Twitter

Compare ACB vs TAK, ZTS, HLN, TEVA, UTHR

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ACB
Aurora Cannabis Inc.
3.425 195.08M 195.82M -88.78M -88.86M -2.5089
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
18.40 57.75B 29.85B 776.90M 4.35B 0.2408
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
128.90 56.70B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.19 49.70B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
34.17 39.96B 17.41B 1.43B 1.00B 1.2182
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
475.21 20.49B 3.13B 1.27B 1.12B 26.39

Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-01-27 Iniziato Canaccord Genuity Buy
2024-12-11 Iniziato TD Cowen Buy
2024-02-09 Aggiornamento Canaccord Genuity Hold → Buy
2022-09-21 Aggiornamento Canaccord Genuity Sell → Hold
2022-06-24 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2022-06-06 Aggiornamento Stifel Sell → Hold
2021-09-28 Aggiornamento MKM Partners Sell → Neutral
2021-09-03 Aggiornamento Jefferies Underperform → Hold
2021-05-14 Aggiornamento BMO Capital Markets Underperform → Market Perform
2021-05-14 Downgrade Canaccord Genuity Hold → Sell
2021-05-11 Downgrade CIBC Neutral → Sector Underperform
2021-04-28 Ripresa BofA Securities Neutral
2021-02-12 Downgrade Desjardins Hold → Sell
2021-02-12 Downgrade MKM Partners Neutral → Sell
2021-02-12 Downgrade Needham Hold → Underperform
2020-12-18 Downgrade BMO Capital Markets Market Perform → Underperform
2020-11-16 Downgrade Jefferies Hold → Underperform
2020-11-11 Downgrade Stifel Hold → Sell
2020-10-27 Downgrade Cantor Fitzgerald Overweight → Neutral
2020-09-21 Aggiornamento Jefferies Underperform → Hold
2020-09-08 Downgrade Ladenburg Thalmann Buy → Neutral
2020-06-24 Aggiornamento Stifel Sell → Hold
2020-05-22 Downgrade Jefferies Hold → Underperform
2020-05-15 Aggiornamento Piper Sandler Underweight → Neutral
2020-02-27 Downgrade Bryan Garnier Neutral → Sell
2020-02-25 Iniziato Needham Hold
2020-02-24 Downgrade Cowen Outperform → Market Perform
2020-02-14 Aggiornamento MKM Partners Sell → Neutral
2020-02-07 Downgrade Canaccord Genuity Speculative Buy → Hold
2020-01-10 Downgrade BofA/Merrill Neutral → Underperform
2020-01-10 Downgrade Piper Sandler Overweight → Neutral
2019-12-23 Downgrade Jefferies Buy → Hold
2019-11-15 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2019-11-05 Iniziato Cantor Fitzgerald Neutral
2019-09-24 Iniziato CIBC Neutral
Mostra tutto

Aurora Cannabis Inc. Borsa (ACB) Ultime notizie

pulisher
Feb 11, 2026

Promising Cannabis Stocks To ConsiderFebruary 11th - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Aurora Advances Global Medical Growth Strategy With Portfolio Expansion in Australia, New Zealand - Cannabis Business Times

Feb 11, 2026
pulisher
Feb 11, 2026

Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand - The Globe and Mail

Feb 11, 2026
pulisher
Feb 11, 2026

Aurora Cannabis expands medical portfolio in Australia and New Zealand - StreetInsider

Feb 11, 2026
pulisher
Feb 10, 2026

Promising Cannabis Stocks To Watch TodayFebruary 10th - MarketBeat

Feb 10, 2026
pulisher
Feb 09, 2026

Aurora Cannabis: 3Q Revenue Jumps on Strong Medical Sales – Quarterly Update Report - Yahoo Finance

Feb 09, 2026
pulisher
Feb 09, 2026

Aurora Cannabis: 3Q Revenue Jumps on Strong Medical Sales – Downloadable Quarterly Report - Yahoo Finance

Feb 09, 2026
pulisher
Feb 09, 2026

Best Cannabis Stocks To ResearchFebruary 9th - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Is Aurora Cannabis Inc impacted by rising ratesWeekly Investment Report & Stock Market Timing Techniques - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 08, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Feb 08, 2026
pulisher
Feb 08, 2026

Cannabis Stocks To Keep An Eye OnFebruary 8th - MarketBeat

Feb 08, 2026
pulisher
Feb 07, 2026

Cannabis Stocks To ResearchFebruary 7th - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

Aurora Cannabis (OTCMKTS:ACBFF) Shares Down 2.9%Here's What Happened - MarketBeat

Feb 07, 2026
pulisher
Feb 06, 2026

Cannabis Stocks To Watch TodayFebruary 6th - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Should you sell your Aurora Cannabis stock? - Cantech Letter

Feb 06, 2026
pulisher
Feb 06, 2026

Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? - The Globe and Mail

Feb 06, 2026
pulisher
Feb 06, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Feb 06, 2026
pulisher
Feb 05, 2026

Best Cannabis Stocks To Keep An Eye OnFebruary 5th - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Aurora Cannabis Launches US$100 Million At-the-Market Equity Program to Fund Growth - The Globe and Mail

Feb 05, 2026
pulisher
Feb 05, 2026

Aurora Cannabis Stock Falls After Consumer Sales Plummet - 富途牛牛

Feb 05, 2026
pulisher
Feb 05, 2026

Aurora Cannabis Inc. (NASDAQ:ACB) Q3 2026 Earnings Call Transcript - Insider Monkey

Feb 05, 2026
pulisher
Feb 05, 2026

Stocks in play: Aurora Cannabis Inc. - Barchart.com

Feb 05, 2026
pulisher
Feb 05, 2026

Aurora Cannabis Inc. (ACB): Investor Outlook With A Promising 69.98% Upside Potential - DirectorsTalk Interviews

Feb 05, 2026
pulisher
Feb 04, 2026

Aurora Cannabis Q3 FY26 slides highlight record global medical revenue amid strategic expansion - Investing.com Australia

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis shares dip after Q3 results show modest revenue growth - AlphaStreet News -

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis Earnings Call Highlights Medical-First Pivot - TipRanks

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis establishes $100 million at-the-market offering By Investing.com - Investing.com Australia

Feb 04, 2026
pulisher
Feb 04, 2026

Promising Cannabis Stocks To Add to Your WatchlistFebruary 4th - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis (TSE:ACB) Hits New 1-Year LowShould You Sell? - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis Sets Up US$100 Million ATM Equity Program With TD Securities - TipRanks

Feb 04, 2026
pulisher
Feb 04, 2026

Investor Outlook: Medical cannabis grows as U.S. reclassification nears - BNN Bloomberg

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis Inc (ACB) (Q3 2026) Earnings Call Highlights: Strategic Shifts and Global ... By GuruFocus - Investing.com Canada

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis Inc (ACB) (Q3 2026) Earnings Call Highlights: St - GuruFocus

Feb 04, 2026
pulisher
Feb 04, 2026

'The company is one of the strongest balance sheets in the cannabis industry': Aurora Cannabis CEO - BNN Bloomberg

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis (ACB) Q3 2026 Earnings Transcript - The Globe and Mail

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis Q3 Earnings Call Highlights - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis Swings To A Loss In Q3 2026 On Record Medical Revenue - thedeepdive.ca

Feb 04, 2026
pulisher
Feb 04, 2026

Q3 2026: Aurora to exit select Canadian consumer markets, doubles down on global medical business - StratCann

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis (NASDAQ: ACB) launches U.S.$100M at-the-market share program - Stock Titan

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis announces filing of prospectus supplement for at-the-market offering program - marketscreener.com

Feb 04, 2026
pulisher
Feb 04, 2026

Earnings call transcript: Aurora Cannabis Q3 2026 shows revenue growth By Investing.com - Investing.com Canada

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis Q3 FY26 slides highlight record global medical revenue amid strategic expansion By Investing.com - Investing.com South Africa

Feb 04, 2026
pulisher
Feb 04, 2026

Earnings call transcript: Aurora Cannabis Q3 2026 shows revenue growth - Investing.com

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis launches new websites for European customers - MMJDaily

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis files prospectus for $100 million share offering program - StreetInsider

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis Up In US Premarket On Q3 Revenue Beat and Bullish FY26 Expectations - 富途牛牛

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis (ACB) Projects Significant Revenue Growth by FY2 - GuruFocus

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora (ACB) Posts Strong Q3 With Record Revenue And Increased E - GuruFocus

Feb 04, 2026
pulisher
Feb 04, 2026

Insights into Aurora Cannabis Q3 Earnings - Benzinga

Feb 04, 2026
pulisher
Feb 04, 2026

Aurora Cannabis Q3 Results Highlight Record Medical Revenue and Strategic Refocus on Core Markets - TipRanks

Feb 04, 2026

Aurora Cannabis Inc. Azioni (ACB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_specialty_generic RDY
$14.23
price up icon 0.18%
$124.44
price down icon 9.04%
drug_manufacturers_specialty_generic RGC
$25.94
price down icon 1.96%
$25.93
price up icon 0.89%
$16.25
price up icon 0.71%
$474.41
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):